Read by QxMD icon Read

hepatic hemangioma guidelines

Teerapat Ungtrakul, Chulabhorn Mahidol, Pattra Chun-On, Charlie Laohapand, Surachate Siripongsakun, Akeanong Worakitsitisatorn, Sirachat Vidhayakorn, Wariya Boonchuay, Jiraporn Dechma, Gaidganok Sornsamdang, Kamonwan Soonklang, Tassanee Sriprayoon, Tawesak Tanwandee, Chirayu U Auewarakul
AIM: To determine the role of screening and surveillance of hepatocellular carcinoma (HCC) in treatment-naïve chronic hepatitis B (CHB) patients. METHODS: We recruited 2293 CHB patients (both males and females; aged 20-65 years). All patients were screened and underwent surveillance using abdominal ultrasonography (AUS) and serum alpha-fetoprotein (AFP) assay every 6 mo. The diagnosis, staging and treatment of HCC followed the American Association for the Study of Liver Diseases practice guidelines and the Barcelona Clinic Liver Cancer guidelines...
September 14, 2016: World Journal of Gastroenterology: WJG
Alexander Semaan, Vittorio Branchi, Anna-Lena Marowsky, Martin VON Websky, Patrick Kupczyk, Simon Jonas Enkirch, Guido Kukuk, Edwin Bölke, Burkhard Stoffels, Jörg C Kalff, Nico Schäfer, Philipp Lingohr, Hanno Matthaei
BACKGROUND: Detection of asymptomatic focal liver lesions (FLL) is increasing because of a widespread use of modern radiologic imaging. Most of these lesions are benign, though malignancy often has to be ruled out, which is posing a diagnostic challenge. AIM: To critically evaluate our treatment strategy in the context of recently published American College of Gastroenterology (ACG) guidelines. PATIENTS AND METHODS: The medical records of patients who underwent surgery for asymptomatic, incidentally detected FLL from 2005-2012 were reviewed...
June 2016: Anticancer Research
Jorge A Marrero, Joseph Ahn, K Rajender Reddy
Focal liver lesions (FLL) have been a common reason for consultation faced by gastroenterologists and hepatologists. The increasing and widespread use of imaging studies has led to an increase in detection of incidental FLL. It is important to consider not only malignant liver lesions, but also benign solid and cystic liver lesions such as hemangioma, focal nodular hyperplasia, hepatocellular adenoma, and hepatic cysts, in the differential diagnosis. In this ACG practice guideline, the authors provide an evidence-based approach to the diagnosis and management of FLL...
September 2014: American Journal of Gastroenterology
Wei Yi, Min Liu, Hao-Dong Cai
AIM: To evaluate the safety of lamivudine (LAM) treatment for chronic hepatitis B in early pregnancy. METHODS: A total of 92 pregnant women who received LAM treatment either before pregnancy or in early pregnancy were enrolled in this study. All of the pregnant women volunteered to take lamivudine during pregnancy and were not co-infected with hepatitis C virus, human immunodeficiency virus, cytomegalovirus, or other viruses. All infants received passive-active immunoprophylaxis with 200 IU hepatitis B immunoglobulin and three doses of 10 μg hepatitis B vaccines (0-1-6 mo) according to the guidelines for the prevention and treatment of chronic hepatitis B...
December 7, 2012: World Journal of Gastroenterology: WJG
Richard M Gore, Kiran H Thakrar, Daniel R Wenzke, Geraldine M Newmark, Uday K Mehta, Jonathan W Berlin
Multidetector-row computed tomography (MDCT) has become the primary imaging test for the staging and follow-up of most malignancies that originate outside of the central nervous system. Technical advances in this imaging technique have led to significant improvement in the detection of metastatic disease to the liver. An unintended by-product of this improving diagnostic acumen is the discovery of incidental hepatic lesions in oncology patients that in the past remained undetected. These ubiquitous, incidentally identified hepatic lesions have created a management dilemma for both clinicians and radiologists: are these lesions benign or do they represent metastases? Naturally, the answer to this question has profound prognostic and therapeutic implications...
2012: Cancer Imaging: the Official Publication of the International Cancer Imaging Society
A Berzigotti, F Piscaglia
No abstract text is available yet for this article.
February 2012: Ultraschall in der Medizin
Tae Kyoung Kim, Kyoung Ho Lee, Hyun-Jung Jang, Masoom A Haider, Lindsay M Jacks, Ravi J Menezes, Seong Ho Park, Leyla Yazdi, Morris Sherman, Korosh Khalili
PURPOSE: To retrospectively identify magnetic resonance (MR) imaging findings that are associated with hepatocellular carcinoma (HCC) in 1-2-cm nodules detected at surveillance ultrasonography (US) and to propose newer MR imaging diagnostic criteria. MATERIALS AND METHODS: Institutional research ethics board approval was obtained, and informed patient consent was waived. Among 145 consecutive patients who had 1-2-cm nodules that were newly detected at surveillance US, 108 patients underwent gadobenate dimeglumine-enhanced MR imaging...
June 2011: Radiology
Roxana Sirli, Ioan Sporea, Alina Martie, Alina Popescu, Mirela Dănilă
UNLABELLED: Contrast enhanced ultrasound (CEUS) has a well established role for the evaluation of focal liver lesions (FLL). The AIM of our paper was to evaluate if CEUS is a cost-efficient method for the first line evaluation of FLL. MATERIAL AND METHOD: We performed a prospective study that included all the CEUS evaluations performed in our Department during a 6 months period (September 2009-March 2010). CEUS evaluation was performed with a Siemens Acuson S2000TM Ultrasound System following an intravenous bolus injection of 2...
December 2010: Medical Ultrasonography
Alejandro Forner, Ramón Vilana, Carmen Ayuso, Lluís Bianchi, Manel Solé, Juan Ramón Ayuso, Loreto Boix, Margarita Sala, María Varela, Josep M Llovet, Concepció Brú, Jordi Bruix
This study prospectively evaluates the accuracy of contrast-enhanced ultrasound (CEUS) and dynamic magnetic resonance imaging (MRI) for the diagnosis of nodules 20 mm or smaller detected during ultrasound (US) surveillance. We included 89 patients with cirrhosis [median age, 65 years; male 53, hepatitis C virus 68, Child-Pugh A 80] without prior hepatocellular carcinoma (HCC) in whom US detected a small solitary nodule (mean diameter, 14 mm). Hepatic MRI, CEUS, and fine-needle biopsy (gold standard) (FNB) were performed at baseline...
January 2008: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
Giuseppe Brancatelli, Michael P Federle, Roberta Ambrosini, Roberto Lagalla, Alessandro Carriero, Massimo Midiri, Valérie Vilgrain
In this article, we present the CT and MR imaging characteristics of the cirrhotic liver. We describe the altered liver morphology in different forms of viral, alcoholic and autoimmune end-stage liver disease. We present the spectrum of imaging findings in portal hypertension, such as splenomegaly, ascites and varices. We describe the patchy and lacelike patterns of fibrosis, along with the focal confluent form. The process of hepatocarcinogenesis is detailed, from regenerative to dysplastic nodules to overt hepatocellular carcinoma...
January 2007: European Journal of Radiology
R T Jensen, F Gibril, B Termanini
There are six major steps in the management of patients with neuroendocrine tumors (NETs) (carcinoids and pancreatic endocrine tumors). One of the steps that is increasing in its importance is the need to assess primary tumor location and tumor extent in these patients. Without such information, it is not possible to adequately manage these patients. Conventional imaging studies (CT scan, MRI, ultrasound, angiography), functional localization studies measuring hormonal gradients, endoscopic ultrasound, and most recently, somatostatin receptor scintigraphy (SRS) with [125I-DTPA-DPhe1]-octreotide have all been advocated to localize NETs in different studies...
September 1997: Yale Journal of Biology and Medicine
S Puleo, I Di Carlo, G Trombatore, R Ciraldo, M Rodolico, L Greco, B Scilletta, A Di Cataldo
Diagnostic and therapeutic findings of benign hepatic tumors are analysed. In particularly the authors describe the more frequent tumors such as angioma, adenoma and FNH, but also give a guidelines on how to approach less frequent lesions.
June 15, 1993: Minerva Chirurgica
P S Maclin, J Dempsey
Radiologists perform differential diagnoses of hepatic (liver) masses using ultrasonography (US), computed tomography (CT), magnetic resonance imaging (MRI), and laboratory tests, but interpretation is often difficult. In our earlier research, a backpropagation neural network was designed to diagnose five classifications of hepatic masses: metastatic carcinoma, hepatoma, cavernous hemangioma, abscess, and cirrhosis. After being trained using ultrasonographic data and laboratory tests, the network classified hepatic masses correctly in 51 of 72 cases...
March 15, 1994: Cancer Letters
G W Creasy, F Flickinger, R E Kraus
The detection of an asymptomatic liver hemangioma as an incidental finding in pregnancy is presented. At the present time a significant amount of data and experience in the diagnosis of hepatic hemangioma by ultrasound and bolus-enhanced sequential computed tomography exists. Although the natural history of liver hemangiomas is not understood completely, the course of asymptomatic, small, single lesions appears to be without any significant complication. Presently the routine use of angiography in liver hemangiomas is unnecessary...
September 1985: Obstetrics and Gynecology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"